Compounds > bromfenac

Page last updated: 2024-08-24

bromfenac and ximelagatran

bromfenac has been researched along with ximelagatran in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (33.33)	29.6817
2010's	4 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Temple, R	1
Senior, JR	1

Reviews

1 review(s) available for bromfenac and ximelagatran

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

5 other study(ies) available for bromfenac and ximelagatran

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Hy's law: predicting serious hepatotoxicity. Pharmacoepidemiology and drug safety, 2006, Volume: 15, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Azetidines; Benzophenones; Benzylamines; Bilirubin; Biomarkers; Bromobenzenes; Chemical and Drug Induced Liver Injury; Chromans; Drug Approval; Humans; Hypoglycemic Agents; Liver; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration	2006
How can 'Hy's law' help the clinician? Pharmacoepidemiology and drug safety, 2006, Volume: 15, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Azetidines; Benzophenones; Benzylamines; Bilirubin; Biomarkers; Bromobenzenes; Chemical and Drug Induced Liver Injury; Chromans; Drug Approval; Humans; Hypoglycemic Agents; Liver; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration	2006